Pure Global AI
Disease / condition

Glioblastoma clinical trials

Free access to 405 studies10+ countriesUpdated daily93 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
405
Total trials
10+
Countries
10+
Sponsors
93
Recruiting
By phase
N/A135
Phase 2108
Phase 171
Early Phase 135
Phase 324
By status
Completed128
Recruiting93
Not yet recruit...66
Unknown37
Terminated30
Top countries
United States of America127
China41
France23
Germany18
Netherlands11
Top sponsors
Massachusetts Gene...8
Dana-Farber Cancer...6
Grupo Español de I...5
Washington Univers...5
Philogen S.p.A.4
Recent trials
Latest clinical trials for Glioblastoma
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Philogen S.p.A.
NCT06336291Not yet recr...
Phase
Phase 2
Evaluate the Role of Anthracycline After Radio Therapy in Patients With Glioblastoma (pGBM).
Iacopo Sardi · Italy
NCT06297512Recruiting
Phase
Phase 2
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Institut Claudius Regaud · France
NCT06222138Not yet recr...
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
Charite University, Berlin, Ge... · Germany
NCT06140875Recruiting
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Charlotte Lemech
NCT06132438Not yet recr...
Phase
Phase 1
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Istituto Clinico Humanitas · Italy
NCT06113705Not yet recr...
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
Beijing Pearl Biotechnology Li... · China
NCT06105619Recruitment ...
Phase
Phase 2/3
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
ImmunityBio, Inc.
NCT06061809Not yet recr...
Phase
Phase 2
Glioblastoma Psychosocial Support Program
Duke University · United States of America
NCT06038604Recruiting
Predictive Value of Soluble CD146 in Glioblastoma Patients
Assistance Publique Hopitaux D...
NCT06001281Not yet recr...
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
Erasmus Medical Center · Netherlands
NCT05970757Recruiting
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Rznomics, Inc.
NCT06102525Not yet recr...
Phase
Phase 1/2
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
Memorial Sloan Kettering Cance... · United States of America
NCT05927610Recruiting
Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors
Mayo Clinic · United States of America
NCT05917145Not yet recr...
Phase
Phase 1
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
CureVac · Belgium,Germany,Netherlands
NCT05938387Recruiting
Phase
Phase 1
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
Ludwig-Maximilians - Universit...
NCT05871021Not yet recr...
Phase
Phase 2
Investigating the impact of a Neuro-Oncology nurse home visiting service in the management of patients with glioblastoma
Monash Medical Centre · Australia
ANZCTR12623000429651Not yet recr...
Phase
Not Applicable
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Second Affiliated Hospital of ...
NCT05811793Not yet recr...
B-amyloid as a Marker for GBM Bioimaging
Universidad Central del Caribe · Puerto Rico
NCT05820191Not yet recr...
Phase
Phase 2
Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
University of Aarhus · Denmark
NCT05768087Not yet recr...
View all 405 trials →
About this profile

Access comprehensive clinical trial information for Glioblastoma through Pure Global AI's free database. This collection includes 405 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 93 trials are actively recruiting participants.

Research for Glioblastoma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Massachusetts General Hospital and Dana-Farber Cancer Institute. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 405 clinical trials studying Glioblastoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Massachusetts General Hospital, Dana-Farber Cancer Institute, Grupo Español de Investigación en Neurooncología, among others.